Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations

Jun Wang, Baocheng Wang, Huili Chu, Yunfeng Yao Department of Oncology, General Hospital, Jinan Command of the People’s Liberation Army, Jinan, People’s Republic of China Abstract: Identifying activating EGFR mutations is a useful predictive strategy that helps select a populat...

Full description

Bibliographic Details
Main Authors: Wang J, Wang B, Chu H, Yao Y
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:OncoTargets and Therapy
Subjects:
NSCLC
EGFR TKIs
intrinsic resistance
Online Access:https://www.dovepress.com/intrinsic-resistance-to-egfr-tyrosine-kinase-inhibitors-in-advanced-no-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/intrinsic-resistance-to-egfr-tyrosine-kinase-inhibitors-in-advanced-no-peer-reviewed-article-OTT

Similar Items